Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5362_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
22 Мб
Скачать
Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery 145
3.2.3 Biomimicry
To generate fully mimetic systems for improved therapeutic efficacy, synthetic materials must mimic biological materials’ functional or structural complexity. Supramolecular biomaterials can mimic biological signal transmission. Amino acid coding components used in biological signaling are already present in materials made from protein building blocks or peptides, whether created by molecular stacking or polymeric antecedents. Tissue engineering and regenerative medicine could benefit from biomaterials that mimic or replace natural components or signaling pathways. To serve as synthetic scaffolds, supramolecular biomaterials mimic fibrous matrix components [75].
3.2.4 Dynamic Reciprocity and Responsiveness
Supramolecular substances can swiftly adapt to multiple external stimuli, mimicking livesystem dynamics due to non-covalent interactions’ dynamic nature. Temperature, voltage, light, magnetic field, pH, redox agent, ionic strength, and competitive host­guest interactions have been used to influence assembly. Smarter treatments can be created by engineering supra-molecular biomaterials that can modify characteristics in real time or autonomously sense and respond to environmental cues. Enzymes that decide whether an oligo peptide may be stacked one-dimensionally govern self-assembling systems with reversible enzymatic switches and protease-responsive components. In biological systems, intricate and interconnected molecule-building and disassembly processes are regulated by competing catalytic pathways, which are influenced by thermodynamic and kinetic factors.

3.3 Applications of Supramolecular Biomaterials

Supramolecular biomaterials have diverse applications, such as drug delivery, engi­neered cell environments, and regenerative medicine. These materials play a crucial role in drug delivery by enabling the precise release of small-molecule pharmaceu­ticals, enhancing the solubility of bioactive proteins, and carrying other medically significant payloads. They possess significant value in the management of cancer. In engineered cell circumstances, these materials function as the substrate or three­dimensional bases that facilitate cell survival, activity, and phenotype control for therapeutic population growth. Lastly, supramolecular biomaterials contribute to advancements in regenerative medicine. Supramolecular biomaterials in each sector enable novel therapies that are impossible using conventional biomaterial production methods.
146 N. T. Tuli et al.
3.3.1 Drug Delivery
The structural components of supramolecular biomaterials allow for controlled drug release. Self-assembled peptides can have drugs added as prosthetic groups through hydrolytic couplings, allowing for controlled and prolonged drug release when hydro­genated. Hybrid peptides with aliphatic chains are efficient drug transporters because their hydrophobic core can contain poorly soluble medications. Numerous method­ologies have been devised to actively control the release rate of a chemical compound by manipulating the stability or dynamic properties of the supramolecular links constituting the substance.
3.3.2 Engineered Cell Microenvironments
Synthetic matrices with adaptable bioactivity, mechanics, and material shape can be built using supramolecular principles for cell support and transport. Therapeutic stem or progenitor cells can be fostered in an optimal environment by inverting supramolecular interactions to generate cell scaffolds amenable to minimally inva­sive delivery. In this particular context, the utilization of three-dimensional matrices composed of peptides or modified proteins has been found to possess bioactive prop­erties and exhibit beneficial effects. Epitopes for integrin attachment are commonly found in supramolecular biomaterials to serve as cell-adhesive cues.
3.3.3 Regenerative Medicine
Supramolecular biomaterials have been demonstrated to regenerate multiple tissues and organs, mostly in preclinical animal models. One of the many therapeutic strate­gies investigated is using materials as scaffolds to promote endogenous tissue repair, deliver soluble growth factors or medications, mimic powerful signaling proteins, deliver therapeutic cell populations, or restore tissue functionality [1]. Because of its limited endogenous regenerating capacity,central nervous system regeneration poses a unique difficulty. Injectable supra-molecular peptides have been used as a strategy for brain regeneration because of their ability to stimulate neuronal reconnection in the aftermath of injury. In mouse models, restoring eyesight following optic nerve amputation by encouraging axon elongation has shown encouraging results. On the other hand, supramolecular biomaterials are being utilized as inductive substances to promote healing processes or provide the controlled release of growth factors that stimulate the natural regeneration of tissues [76].
3.3.4 Immuno-Engineering
Immunomodulation techniques like prophylactic vaccination or reducing inflamma­tion and autoimmunity have recently garnered attention. Supramolecular systems

Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery 147

can deliver soluble drugs and immunomodulating signals. In a chronic obstruc­tive nephropathy model, tailored recombinant protein hydrogels delivered IL-10 to protect against inflammation. T and B-cell epitopes can be shown via supramolec­ular peptide assemblages, eliciting cellular and humoral responses from the immune system. Strong immune responses can be elicited without an adjuvant by presenting high densities of epitopes on supramolecular peptide fibrils. The supramolecular distribution of natively folded entire protein antigens utilizing a fibrillating domain as a template elicits a strong immunological response.
3.3.5 Supramolecular Chemistry in Molecular Imaging
In the early 1990s, Brad Smith made significant contributions to the domains of ion­pair receptors, transport through membranes, and rotaxane synthesis. Eventually, he integrated his research in molecular imaging with his work in rotaxane synthesis [77]. Incorporating a guest molecule into a macrocyclic host molecule, forming a rotaxane, involves threading the guest molecule through the host molecule. This threaded structure is subsequently sealed at both ends using certain functions to ensure the macrocycle remains securely attached and does not detach [78].
4 Carbon Nanomaterial-Incorporated Supramolecular
Drug Delivery
4.1 Carbon Nanomaterials as Building Blocks
for Supramolecular Structures
Carbon nanotubes (CNTs) have emerged as a prominent subject of study in nanome­chanics. Carbon nanotubes (CNTs) possess an atomically perfect structure, elongated and hollow in shape, with a surface absent in single-walled nanotubes (SWNTs). Additionally, their high covalent bond strength renders t hem exceptionally well­suited for applications in the field of nanomechanics. The term “resilient” was initially employed in investigating high-energy collisions involving smaller fullerene cages, such as C The resilient cages of fullerenes exhibited remarkable elastic deformation tolerance, as they remained intact and undistorted despite the impact. Carbon nanotubes (CNTs) are nanocrystals with well-defined primordial cells, transportability, surface, etc. The stiffness, moduli, compliance, geometry, and geometric scale of engineering structures can be studied. Nanotubes are intriguing because of their mesoscopic size (a nanometer diameter) and homogeneous, almost translation-invariant shape throughout micrometer lengths.
Furthermore, carbon has a remarkable capacity to construct diverse forms, rendering it one of the most captivating components. Various allotropes of carbon
, and C84, rebounding off a diamond wall terminated with hydrogen.
60,C70
148 N. T. Tuli et al.
have been identified depending on the valence of carbon atoms, including carbon quantum dots, zero-dimensional fullerenes, two-dimensional graphene sheets, and one-dimensional carbon nanotubes (CNTs). Diamond as well as graphite are both allotropes of carbon. Diamond is a hard material, whereas graphite is relatively soft. Diamonds, along with graphite, include carbon atoms arranged in hexagonal or cubic
2
lattices. The carbon atoms in both materials exhibit sp
or sp3hybridization. Carbon nano-onions (CNOs) have garnered significant attention from both academic and commercial sectors due to their various applications in biology [79]. Using carbon nanostructures in medical applications is highly desirable depending on exceptional characteristics such as substantial surface area, electrical conductivity, mechanical robustness, and various other advantages [80]. This review included a variety of carbon-based nanomaterials (CNMs), each with their strengths and cons (Table 1).
The ability to stack supramolecular is the key to their great drug absorption.
CNMs have distinct optical properties and combine well with luminous substances, making them potential theragnostic.
Furthermore, it is worth noting that carbon nanomaterials (CNMs) exhibit a remarkable ability to convert heat, particularly in the near-infrared spectrum. This characteristic makes CNMs highly suitable for applications in photothermal therapy.
Tunable surface chemistry helps to regulate drug release.
In the context of biological applications, using covalent and non-covalent func­tionalization techniques on carbon-based nanomaterials (CNMs) has been shown to enhance the colloidal stability of these materials in aqueous solutions. Oxida­tion, dehydrogenation, plasma, and ozonolysis are covalent functionalization tech­niques. CNMs can cross biological membranes and deliver drugs. Functionaliza­tion with a specific ligand minimizes loaded drug cytotoxicity to healthy cells and improves therapy. Drug-loaded carbon nanomaterials (CNMs) have the potential to be coupled with various small targeting molecules. Some solid tumor cells exhibit folate receptors on their surface, which can be targeted using folic acid. Tumor­associated antigens can also be identified using antibodies, and ligands having an affinity towards a receptor overemphasized on a particular tumor type can be used. In addition, drug-loaded CNMs can benefit from adding magnetic nanoparticles, increasing their specificity. Carbon nanomaterials (CNMs) have many potential uses in oncology, s uch as in the creation of anticancer medications, the discovery of fluo­rescent markers for tumor identification, the administration of cancer phototherapy, and the performance of theragnostic.
Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery 149
Tabl e 1 CNMs’ benefits and drawbacks. Adapted and reproduced with permission from MDPI [80]
Serial number
1 Graphene quantum
2 Nanodiamonds TheCNMshaveseveraldesirable
3 Fullerenes Superconductivity,
4 Carbon nanotubes Very high aspect ratio, mechanical
5 Carbon
Carbon-based nanomaterials
dots/graphene oxide/graphene
nano-onions
Effects Confines in biomedical
Superior electrical, thermal, and optical properties. Graphene’s atomic sheet structure in just two dimensions gives it superior electrical characteristics versus CNTs
properties, including fluorescence and photoluminescence, a smaller size than competing CNMs, resistance to corrosion and durability, as well as high electrical and chemical inertness
photoelectrochemistry, and surface modification
strength, chemical stability, and conductivity. Offers high surface area, biocompatibility, and the ability to tune its physical properties
Exceptional electrical and structural properties, including reversible electron uptake, broad absorption bands, and a high surface-to-volume ratio
applications
Colloidal instability, repeatability, poor chemical stability, limited synthetic control in biological environments, and oxidative vulnerability
Covalent manufacturing, toxic organic solvent removal, sudden drug release, and inclination to agglomerate make it difficult
Low aqueous solubility, cell membrane accumulation, light and oxygen degradation, quenching susceptibility
Non-homogenous size (length and diameter) and metallic impurities. Powdery Pristine CNTs can enter the respiratory tract
Aggregation, hydrophobicity, insufficient surface chemical reactivity, oxidation susceptibility, and poor biocompatibility
4.2 Examples of Carbon Nanomaterial-Incorporated
Supramolecular Drug Delivery Systems
4.2.1 Carbon Nanotubes (CNTs) for Drug Delivery
Scientist Ijima used the carbon arc discharge method to create “multi-walled carbon nanotubes,” needle-like graphene sheets, in the early 1990s [25]. Compared to other materials used for sensing, diagnostics, and medication delivery, single- and multi­walled carbon nanotubes (CNTs) are superior because of their exceptional structural, electrical, and mechanical capabilities. The confinement of quantum particles along the tube’s axis conserves electrons. CNTs also exhibit van Hove singularities and
150 N. T. Tuli et al.
a uniform Density of States (DoS). Diameter and chirality determine the DoS. The valence-conduction band gap decreases with the diameter of CNTs. Both bands create metallic nanotubes. Pristine CNTs are hydrophobic due to their size, struc­ture, and bundling effect, restricting their biological absorption. Functionalization reduces nanotube surface bundling, enhancing biocompatibility and cellular inter­nalization. Functionalized nanotubes were biocompatible in vivo and in vitro. The level of functionalization is determined by factors such as sidewall behavior, reac­tivity (curvature), the number of attachable functional groups, and the steric barrier between the functional categories and the nanotube sidewall. Various methods can be employed to affix drugs onto carbon nanotube (CNT) sidewalls, including both cova­lent and noncovalent bonding approaches. Table 2 lists drug delivery breakthroughs using carbon nanotubes (CNTs).
4.2.2 Graphene Oxide (GO) for Drug Delivery
Simple physisorption by stacking can absorb DOX, antibodies, and docetaxel onto graphene. Graphene’s ability to stack and interact electrostatically or hydropho­bically allows for the safe transfer of pharmaceuticals that aren’t easily soluble. Table 3 shows GO-based medicine delivery uses. Using graphene oxide-zoledronic acid (ZOL-GO), Mahor et al. [80] studied cells in vitro. The morphology of MCF-7 breast cancer cells and the mineralization of BM-MSCs were analyzed. Nanostruc­tured ZOL-GO mineralized BM-MSC cells in clusters. Highly effective quercetin­loaded single-layer graphene oxide (GO) sheets, grafted with hyperbranched polymer (HPG) on their surface, were successfully synthesized through the polymerization of glycidol. The Hummers process was enhanced. Drug-loading and encapsulating HPG stabilized GO sheets in biological fluids. The administration of quercetin was regulated and maintained by HPG-GO, while it was proposed that an acidic pH could enhance the release of the medicine.
4.2.3 Carbon Nano-Onions (CNOs) for Therapeutics Delivery
CNOs are extensively exploited in drug administration, tissue engineering, bioimaging, sensing, cancer treatment, and CNS diseases (Table 4). Using supramolecular functionality in the context of stimuli-responsive biocompatible polymers enables the controlled delivery of customized pharmaceutical agents through carbon nanotubes (CNOs) [94]. Narsimha et al. developed a nanocomposite fiber consisting of bovine serum albumin (BSA) embedded with Forcespinning® (FS) 4-hydroxyphenyl methacrylate-carbon nano-onions (PHPMA-CNOs = f-CNOs). This fiber was designed to administer doxorubicin (DOX) in a stimuli-responsive manner [17].
Tabl e 2 Recent development in transport using carbon nanotubes. Adapted and reproduced with permission from MDPI [80]
Serial
Disease CNT functionalization Drug/Vaccines/Genes Results References
Number
1 Cancer MWCNTs/Gemcitabine (Ge)/
Lentinan-Le
Gemcitabine–Lentinan Increased chemotherapeutic and synergistic
photothermal action against tumors were seen using MWCNTs-Ge-Le
2 Bladder cancer Magnetic MWCNTs-Epi Epirubicin (Epi) The application of an external magnetic field
significantly enhanced the anticancer activity of multi-walled carbon nanotubes (MWCNTs) in both in vitro and in vivo settings, surpassing the effectiveness of free epirubicin
3 Cell proliferation Hydrogels of PEG-CNTs Tissue engineering The cytocompatibility, proliferation of L29
fibroblasts and viability were all improved by exposure to pure CNTs and PEG-CNT hydrogels
4 Ischemic brain
tissue
PEGylated vertically aligned MWCNTs
Dexamethasone The MWCNTs exhibited minimal cytotoxicity when
tested on the PC-12 cell line
5 Antileishmanial Ci-SWCNTs, Ci-MWCNTs Cisplatin (Ci) In vitro, the growth of Leishmania major was
effectively suppressed by Ci-MWCNTs at low concentrations
6 Cancer therapy N-isopropyl acrylamide
carbon nanotubes loaded with DOX
Doxorubicin (DOX) The incorporation of a five-mer N-isopropyl
acrylamide molecule resulted in enhanced DOX loading through the formation of hydrogen bonds with the drug
Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery 151
[80]
[81]
[82]
[83]
[84]
[85]
(continued)
Tabl e 2 (continued)
Serial Number
7 Antibacterial
8 Peptide delivery The casing of SWNTs with
Disease CNT functionalization Drug/Vaccines/Genes Results References
activity
Glucose-modified calcium alginate single-walled carbon nanotubes (CA/SWCNT-Gl)
polycationic and amphiphilic peptides [H-(-Lys-Trp-Lys-Gly-)7-OH]
Curcumin The Gl nanocomposite exhibited superior efficacy
compared to Escherichia coli and Bacillus cereus compared to CA/SWCNT
GS-protein PEGylation increases absorption by seven times [87]
[86]
152 N. T. Tuli et al.
Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery 153
Tabl e 3 Drug delivery using graphene derivatives. Adapted and reproduced with permission from MDPI [80]
Serial number
1 GO Zoledronic acid Bone marrow-derived
2 GO Doxorubicin In vitro: drug statement [89]
3 Pristine graphene andGODoxorubicin In vitro: pH imitation [90]
Graphene derivative Therapeutic agents Application and outcomes References
[88] mesenchymal stem cells (BM-MSC) and Michigan Cancer Foundation-7 (MCF-7) breast cancer cells
4 PEG-functionalizedGOCephalexin CEF release in vitro was
5 GO nanosheets
doped into ZnO NPs
6 GO Chloramphenicol,
Doxorubicin The drug loading accuracy
ampicillin, tetracycline
burst, constant, and 80% cumulative. GO-PEG-CEF’s antibacterial efficacy against Gram-positive and Gram-negative bacteria was dose- and time-dependent
was 89% for GO-doped ZnO NPs and 82% for ZnO. The system improved drug dissolution
GO synergistically kills P. aeruginosa, E. faecalis, and E. coli, and harms human epidermal keratinocytes (HaCaT)
[91]
[92]
[93]
5 Drug Delivery Systems Based on Carbon Nanomaterials
Associated with Supramolecules
In recent years, there has been a notable increase in the interest in drug delivery methods that utilize carbon nanomaterials in conjunction with supramolecules such as cyclodextrin, calixarenes, cucurbituril, pillarenes, and crown ether. These systems exhibit potential for optimizing the targeted administration of pharmaceuticals, improving their bioavailability, and mitigating potential adverse effects. Here’s a concise summary of the various applications of supramolecular structures in drug delivery systems incorporating carbon nanomaterials.
Tabl e 4 CNO biomedical advancements. Adapted and reproduced with permission from MDPI [80]
Serial number Delivery system Application Results Reference
1 f-CNO-reinforced zein hydrogels Anticancer drug delivery Zein hydrogels were fortified by f-CNOs.
[95] The mode of distribution proved safe for osteoblasts to process. The pH-dependent release of the drug lasted for 15 days
2 Ox-CNO-loaded chitosan polyvinyl alcohol
(CS/PVA/oc-CNO) nanocomposite film
Tissue engineering application The scaffold composed of CS/PVA/ox-CNO
exhibited enhanced stability. The Wistar rats
[96]
that were subjected to implantation of the nanocomposite film did not exhibit any adverse reactions or the formation of pus. The CS/PVA/oc-CNO scaffold demonstrated the capability for tissue regeneration
3 Polycaprolactone/f-CNO nanocomposite
fiber
Anticancer drug delivery PCL or f-CNO nanocomposite fiber released
DOX pH-dependently. PCL nanofibers were
[97]
stronger, hydrophobic, and biocompatible with F-CNOs
(continued)
154 N. T. Tuli et al.